Description of Research Expertise

I am currently a principal investigator in the Phase 1 clinical trial program at Penn, and also for ECOG-affiliated trials in the Penn GI oncology clinical research program, with my clinical focus being colorectal and anal cancers. I am the principal investigator for 2 trials which are currently open and accruing patients at Penn. I am also the Medical Monitor for Medical Monitor for UPCC trial 05519, and the
Medical Director for UPenn: Observational Study of a Combined Infusion System to Deliver Chemotherapy Regionally to the Liver, intended to produce a new IND for the FDA combining the Medtronics hepatic artery infusion pump with the Codman hepatic artery infusion catheter.

Description of Clinical Expertise

I am a gastrointestinal oncologist with expertise in all subtypes of GI malignancies but with special expertise with national recognition in colorectal, anal, small intestine, appendiceal, liver metastases (HAI chemotherapy for mCRC), and peritoneal mucinous malignancies. I serve as the Penn representative on NCCN guidelines committees for colon, rectal, anal, small intestine and appendix cancers; the Peritoneal Oncology Consortium; and the Hepatic Artery Infusion Research Consortium Network (HRCN)